The novel coronavirus disease 2019 (COVID-19) has grown to be a global public-health emergency since patients were first detected in Wuhan, China, in December 2019. As of April 9, 2020, the novel coronavirus (named as SARS-CoV-2 by the International Committee on Taxonomy of Viruses on February 11) has infected 83,251 and 1,484,811 patients in China and the world, respectively. However, we have neither confirmed effective antiviral medications nor vaccines available to deal with this emergency. In this commentary, we offer an alternative promising therapy for COVID-19, that is, mesenchymal stem cell transplantation.
Get full access to this article
View all access options for this article.
References
1.
HuangC, WangY, LiX, RenL, ZhaoJ, HuY, ZhangL, FanG, XuJ, GuX, ChengZ, YuT, XiaJ, WeiY, WuW, XieX, YinW, LiH, LiuM, XiaoY, GaoH, GuoL, XieJ, WangG, JiangR, GaoZ, JinQ, WangJ and CaoB. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395:497–506.
2.
GuanWJ, NiZY, HuY, LiangWH, OuCQ, HeJX, LiuL, ShanH, LeiCL, HuiDSC, DuB, LiLJ, ZengG, YuenKY, ChenRC, TangCL, WangT, ChenPY, XiangJ, LiSY, WangJL, LiangZJ, PengYX, WeiL, LiuY, HuYH, PengP, WangJM, LiuJY, ChenZ, LiG, ZhengZJ, QiuSQ, LuoJ, YeCJ, ZhuSY and ZhongNS. (2020). Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med [Epub ahead of print];, DOI: 10.1056/NEJMoa2002032.
3.
GrasselliG, ZangrilloA, ZanellaA, AntonelliM, CabriniL, CastelliA, CeredaD, ColuccelloA, FotiG, FumagalliR, IottiG, LatronicoN, LoriniL, MerlerS, NataliniG, PiattiA, RanieriMV, ScandroglioAM, StortiE, CecconiM, Pesenti and COVID-19 Lombardy A, Network ICU. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA [Epub ahead of print];, DOI: 10.1001/jama.2020.5394.
4.
YoungBE, OngSWX, KalimuddinS, LowJG, TanSY, LohJ, NgO-T, MarimuthuK, AngLW, MakTM, LauSK, AndersonDE, ChanKS, TanTY, NgTY, CuiL, SaidZ, KurupathamL, ChenMI-C, ChanM, VasooS, WangL-F, TanBH, LinRTP, LeeVJM, LeoY-S, Lye and Singapore 2019 Novel Coronavirus Outbreak Research Team DC. (2020). Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA [Epub ahead of print];, DOI: 10.1001/jama.2020.3204.
5.
National Health Commission and National Administration of Traditional Chinese Medicine. (2020). Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chinese Med J, 133:E027–E027.
6.
OmerSB, MalaniP and del RioC. (2020). The COVID-19 pandemic in the US: a clinical update. JAMA [Epub ahead of print];, DOI: 10.1001/jama.2020.5788.
7.
XuX, ChenP, WangJ, FengJ, ZhouH, LiX, ZhongW and Hao.P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci, 63:457–460.
8.
HoffmannM, Kleine-WeberH, SchroederS, KrügerN, HerrlerT, ErichsenS, SchiergensTS, HerrlerG, WuN-H, NitscheA, MüllerMA, DrostenC and PöhlmannS. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell [Epub ahead of print];, DOI: 10.1016/j.cell.2020.02.052.
GuoH, HuY, LiaoLM, JiangXY, LiuJW, MaL, MaGJ, ZhaoZG, YangSG, and ZhaoRC. (2002). Postembryonic subtotipotent stem cells derived from a variety of fetal tissues have multiple differentiation potential and greatly contribute to stem cell plasticity. China J Mod Med, 12:1–9.
LengZ, YinD, ZhaoZ, YanM, YangY, HeX, ZhaoRC and LiuH. (2020). A survey of 434 clinical trials about coronavirus disease 2019 in China. J Med Virol [Epub ahead of print];, DOI: 10.1002/jmv.25779.
